A literature review of treatment-specific clinical prediction models in patients with breast cancer

Crit Rev Oncol Hematol. 2020 Apr:148:102908. doi: 10.1016/j.critrevonc.2020.102908. Epub 2020 Feb 17.

Abstract

Despite advances in the breast cancer treatment, significant variability in patient outcomes remain. This results in significant stress to patients and clinicians. Treatment-specific clinical prediction models allow patients to be matched against historical outcomes of patients with similar characteristics; thereby reducing uncertainty by providing personalised estimates of benefits, harms, and prognosis. To achieve this objective, models need to be clinical-grade with evidence of accuracy, reproducibility, generalizability, and be user-friendly. A structured search was undertaken to identify treatment-specific clinical prediction models for therapeutic or adverse outcomes in breast cancer using clinicopathological data. Significant gaps in the presence of validated models for available treatments was identified, along with gaps in prediction of therapeutic and adverse outcomes. Most models did not have user-friendly tools available. With the aim being to facilitate the selection of the best medicine for a specific patient and shared-decision making, future research will need to address these gaps.

Keywords: Breast cancer; Clinical prediction model; Literature review; Treatment-specific.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Clinical Decision-Making
  • Decision Support Techniques
  • Female
  • Humans
  • Predictive Value of Tests
  • Prognosis
  • Reproducibility of Results